可预测克罗恩病术后复发的可成药靶点鉴定
研究对回结肠切除术后克罗恩病患者回肠组织进行无偏转录组学分析,发现肠上皮谷胱甘肽过氧化物酶4(GPX4)表达降低与内镜下复发相关,并在三个独立队列中验证其预测价值,小鼠模型中补硒恢复GPX4可减轻肠炎。
要点
- 肠上皮GPX4表达降低在手术时即可预测内镜下复发。
- GPX4表达与内质网应激特征负相关,与遗传变异无关。
- 小鼠中补硒恢复GPX4表达可改善严重肠炎。
核心结论
- 肠上皮GPX4低表达是可成药生物标志物,能改善内镜下克罗恩病复发的预测。
研究设计与样本
- 对回结肠切除术后回肠组织进行无偏转录组学分析,比较Rutgeerts评分i0与≥i2b患者(N=36)。
- 在3个独立回结肠切除队列(总N=241)中验证GPX4蛋白预测内镜复发的价值。
- 使用小鼠肠炎模型研究功能意义和治疗潜力。
主要发现
- 内镜复发患者转录节点以肠上皮GPX4表达降低为特征。
- 手术时肠上皮GPX4表达降低即可预测内镜复发,且独立于已有临床风险因素。
- GPX4表达与黏膜内质网应激特征负相关,与GPX4遗传变异、炎症组织学严重程度或临床复发风险因素无关。
- 小鼠中肠上皮Gpx4表达降低促进内质网应激并导致严重肠炎,补硒恢复GPX4表达可改善。
临床怎么用
- 手术时检测肠上皮GPX4表达可能辅助预测克罗恩病内镜复发风险。
- 补硒恢复GPX4表达是潜在治疗策略,尚需临床验证。
局限性
- 研究未报告GPX4预测复发的具体阈值、敏感度或特异度。
- 补硒的治疗潜力仅在小鼠模型中得到验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Molecular phenotyping of Crohn's disease (CD) trajectories after ileocolonic resection (ICR) enables the identification of evolving disease mechanisms and related biomarker discovery. Here, we aimed at identifying a pathogenic node with predictive value for endoscopic disease recurrence after ICR in CD. METHODS: We performed unbiased transcriptomics of the postoperative ileum, comparing patients with an endoscopic Rutgeerts score i0 vs those with ≥i2b (N = 36). A potential biomarker from this analysis was then validated at the protein level by quantitative confocal microscopy on tissue slides, and its value for predicting endoscopic recurrence at resection was assessed in 3 independent ICR cohorts (total N = 241). Functional implications and therapeutic potential were investigated in mouse enteritis models. RESULTS: Patients with endoscopic CD recurrence exhibited a transcriptional node characterized by reduced glutathione peroxidase 4 (GPX4) expression, which was confined to the intestinal epithelium. Reduced intestinal epithelial GPX4 expression was already observed at the time of ICR and predicted endoscopic recurrence in addition to established clinical risk factors in a patient-level meta-analysis. Intestinal epithelial GPX4 expression was a surrogate of its enzymatic activity, inversely correlated with a mucosal endoplasmic reticulum stress signature, but was unrelated to a GPX4 genetic variant associated with CD susceptibility, histologic severity of inflammation, or clinical risk factors for recurrence. In mice, reduced intestinal epithelial Gpx4 expression fueled endoplasmic reticulum stress and enabled severe enteritis, which was ameliorated by restoration of epithelial GPX4 expression with selenium supplementation. CONCLUSIONS: Collectively, our study identifies a druggable biomarker that improves the prediction of endoscopic CD recurrence, potentially guiding patient management and therapy in the future. One of the studied ICR cohorts was part of the REMIND (Groupe de Recherche sur les Maladies inflammatoires digestives) study, registered at ClinicalTrials.gov (NCT03458195).
引用
- Verstockt S, Schwärzler J, Willeit P, et al. Identification of a Druggable Target That Predicts Postoperative Crohn's Disease Recurrence. Gastroenterology. 2026. PMID: 41850538. doi:10.1053/j.gastro.2026.02.035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。